-
Commercialization of US Patents, Licensing or Sales Outright US Patents to Technology IP & Patents Funds
Biologics, Small Molecules and Medical Devices US Patents
HQS – Boston, MA
HQS – Lausanne, Switzerland
OUR CURRENT PLAN FOR FUNDING GDE’s BUSINESS #4
- 4.1, 4.2, 4.3, 4.4 are under discussion with one of our Investment Houses (Paris)
- We need a similar Foundation to Melinda and Bill Gates that accept proposals for start ups in Biotech and Scientific Media for 4.5 and 4.6
- Commercialization of US Patents
4.1 (Dr. Pearlman – Cardiovascular and other Medical Devices) – 12 Patents before met Aviva, two joint concepts after met Aviva, on PPA on 3D Printing of Stents coated by EPCs and NO (Aviva has prior art.)
4.2 (Bill Zurn – Cardiovascular and other Medical Devices) US Patents before and after met Aviva
Any Development of MEMS and 3D Printing is UNDER GDE’s M3DP
4.3 (Dr. Nir, SBH Sciences – Cytokines)
Any development of Hydrogel and Cytikines using 3D BioPrinting is UNDER GDE’s M3DP
4.4 (Dr. Briggs – Biologics – cancer galactic-3 and Liver Fibrosis) needs investment
4.5 NEW (Dr. Codrington, Cambridge, UK) – Diagnostics, Antibodies in Hematology) – Candidate for Foundation Funding or M&A with Diagnostics Leader
4.6 NEW (Dr. Evelyna Cohn, Richmond, VA) – BioChemical Coating of Protective Equipment against RNA Viruses Epidemic – Candidate fof Foundations or Public Governmental Funding Sources